Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia

[img]
Preview
PDF (Original Article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
3MB
[img]
Preview
PDF (Supplementary Information) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
2MB

Item Type:Article
Title:Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia
Creators Name:Kuhrt, L.D. and Motta, E. and Elmadany, N. and Weidling, H. and Fritsche-Guenther, R. and Efe, I.E. and Cobb, O. and Chatterjee, J. and Boggs, L.G. and Schnauß, M. and Diecke, S. and Semtner, M. and Anastasaki, C. and Gutmann, D.H. and Kettenmann, H.
Abstract:Neurofibromatosis type 1 (NF1) is an autosomal dominant condition caused by germline mutations in the NF1 gene. Children with NF1 are prone to the development of multiple nervous system abnormalities, including autism and brain tumors, which could reflect the effect of NF1 mutation on microglia function. Using heterozygous Nf1-mutant mice, we previously demonstrated that impaired purinergic signaling underlies deficits in microglia process extension and phagocytosis in situ. To determine whether these abnormalities are also observed in human microglia in the setting of NF1, we leveraged an engineered isogenic series of human induced pluripotent stem cells to generate human microglia-like (hiMGL) cells heterozygous for three different NF1 patient-derived NF1 gene mutations. While all NF1-mutant and isogenic control hiMGL cells expressed classical microglia markers and exhibited similar transcriptomes and cytokine/chemokine release profiles, only NF1-mutant hiMGL cells had defects in P2X receptor activation, phagocytosis and motility. Taken together, heterozygous NF1 mutation impairs a subset of human microglia functional properties, which could contribute to the neurological abnormalities seen in children with NF1.
Keywords:Microglia, Neurofibromatosis 1, Human Induced Pluripotent Stem Cells, Purinergic Receptors, Phagocytosis, Motility, Animals, Mice
Source:Disease Models & Mechanisms
ISSN:1754-8403
Publisher:Company of Biologists
Volume:16
Number:12
Page Range:dmm049861
Date:December 2023
Official Publication:https://doi.org/10.1242/dmm.049861
PubMed:View item in PubMed

Repository Staff Only: item control page

Downloads

Downloads per month over past year

Open Access
MDC Library